Suppr超能文献

相似文献

1
3
High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications.
Histopathology. 2022 Dec;81(6):732-741. doi: 10.1111/his.14775. Epub 2022 Sep 23.
5
PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation.
Virchows Arch. 2021 May;478(5):827-839. doi: 10.1007/s00428-020-02976-5. Epub 2020 Dec 4.
6
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas.
Mod Pathol. 2016 Oct;29(10):1165-72. doi: 10.1038/modpathol.2016.117. Epub 2016 Jul 8.
7
Comparability of PD-L1 immunohistochemistry assays for non-small-cell lung cancer: a systematic review.
Histopathology. 2020 May;76(6):793-802. doi: 10.1111/his.14040. Epub 2020 Mar 24.
9
Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis.
Mod Pathol. 2020 Mar;33(3):380-390. doi: 10.1038/s41379-019-0349-y. Epub 2019 Sep 16.

引用本文的文献

1
Artificial intelligence-assisted HER2 interpretation for breast cancers in a multi-laboratory study.
Gland Surg. 2025 Jun 30;14(6):1042-1051. doi: 10.21037/gs-2024-560. Epub 2025 Jun 26.
2
Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.
Diagnostics (Basel). 2024 Sep 10;14(18):2003. doi: 10.3390/diagnostics14182003.
3
Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides.
Breast Cancer Res. 2024 Aug 19;26(1):124. doi: 10.1186/s13058-024-01863-0.
4
Measuring disability among U.S. adolescents and young adults: A survey measurement experiment.
Prev Med Rep. 2024 May 23;43:102770. doi: 10.1016/j.pmedr.2024.102770. eCollection 2024 Jul.
6
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.
Mod Pathol. 2023 Jan;36(1):100032. doi: 10.1016/j.modpat.2022.100032.
8
Development of an immunohistochemical assay for Siglec-15.
Lab Invest. 2022 Jul;102(7):771-778. doi: 10.1038/s41374-022-00785-9. Epub 2022 Apr 22.

本文引用的文献

4
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20.
5
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.
J Thorac Oncol. 2018 Sep;13(9):1302-1311. doi: 10.1016/j.jtho.2018.05.013. Epub 2018 May 22.
9
A unified approach for assessing agreement for continuous and categorical data.
J Biopharm Stat. 2007;17(4):629-52. doi: 10.1080/10543400701376498.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验